US · Healthcare · Diagnostics & Research
EPS came in at -0.01 against a street estimate of -0.08 — a beat of 87.5%.
Analysts rate Opko Health Inc a buy (6 buy, 1 hold, 0 sell out of 7) with an average price target of $4.38.
| Fund | Stake |
|---|---|
| Rubric Capital Management LP | 6.40% |
| BlackRock Inc | 4.85% |
| Vanguard Portfolio Management, LLC | 1.98% |
| Vanguard Capital Management, LLC | 1.94% |
| Geode Capital Management, LLC | 1.51% |
| State Street Corp | 1.27% |
| The Goldman Sachs Group Inc | 1.03% |
| UBS Group AG | 0.81% |
| Document | Date |
|---|---|
| Material agreement · Q3 2026 OPKO HEALTH, INC. - 8-K SUMMARY HEADLINE NUMBERS • Company issued $125,000,000 in additional senior secured notes on August 13, 2026 • Notes mature | 2026-08-14 |
| Quarterly report · Q2 2026 OPKO HEALTH, INC. - 10-Q SUMMARY (Q2 2026) HEADLINE NUMBERS • Total Revenues (6 months ended June 30, 2026): $287.8 million vs. $306.8 million (2025 | 2026-07-27 |
| Results announced · Q3 2026 OPKO HEALTH Q2 2026 RESULTS SUMMARY HEADLINE NUMBERS • Q2 2026 Total Revenues: $163.5 million vs. $156.8 million in Q2 2025 (+4.3%) • Q2 2026 Net Lo | 2026-07-27 |
| Shareholder vote results · Q2 2026 OPKO HEALTH, INC. - 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting held June 18, 2026 • 11 Board directors elected with strong approval margins • Tot | 2026-06-18 |
| Proxy statement · Q2 2026 OPKO HEALTH, INC. – PROXY SUMMARY FOR RETAIL INVESTORS CEO COMPENSATION • Phillip Frost, M.D. (CEO & Chairman): Total compensation figure not explic | 2026-04-30 |
| Quarterly report · Q1 2026 OPKO HEALTH, INC. — Q1 2026 10-Q SUMMARY --- HEADLINE NUMBERS • Total revenues (Q1 2026): $124.2 million vs. $150.0 million (Q1 2025) — decline of | 2026-04-28 |
| Results announced · Q2 2026 OPKO HEALTH Q1 2026 FINANCIAL SUMMARY HEADLINE NUMBERS • Total Q1 2026 Revenue: $124.2 million vs. $149.9 million in Q1 2025 (down 17%) • Q1 2026 Ne | 2026-04-28 |
| Annual report FY2025 OPKO HEALTH, INC. – 2025 10-K SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Fiscal Year Ended: December 31, 2025 • Public Float (as of Q2 2025): $ | 2026-02-26 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Opko Health Inc — free to start.
Google PlayApp StoreData updated 2026-09-18.